devimistat,panitumumab
rafael pharma,takeda,amgen
['improve ', 'devimistat']
avenger500 devimistat/cpi-613 in combination wit mfolfirinox does not improve survival in pca. promising phase-1 data: orr61%, mpfs 11.5
not reproduced in phase-iii
pca remains a challenge 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine